Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2025-03-06 00:00:00 ET · period of report 2025-03-04 · accession 0001415889-25-007241 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-06 | 2025-03-04 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | S - Sale+OE | $27.54 | -4,231 | 97.4K | -4% | -$116.5K |
| D | 2025-03-06 | 2025-03-04 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | F - Tax | $27.62 | -1,739 | 95.6K | -2% | -$48.0K |
| D | 2025-03-06 | 2025-03-04 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | M - OptEx | $13.35 | +7,490 | 101.6K | +8% | +$100.0K |
| D | 2025-03-06 | 2025-03-04 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | M - OptEx | $0.00 | -7,490 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-04 | S | D | 4,231 | $27.54 | 97,363 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.21 to $28.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-03-04 | F | D | 1,739 | $27.62 | 95,624 | D | — | — | (F4) The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs. |
| 3 | Common | Common Stock | 2025-03-04 | M | A | 7,490 | $13.35 | 101,594 | D | — | — | (F1) Includes one share acquired under the Issuer's 2014 Employee Stock Purchase Plan on November 30, 2024. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2025-03-04 | M | D | 7,490 | $0.00 | 0 | D | $13.35 · — to 2027-03-16 | 7,490 Common Stock | (F5) Shares subject to the option are fully vested and immediately exercisable. |